Atlas Trials

Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients

Clinical trial NCT00287131 · UNKNOWN

Trial details

NCT number
NCT00287131
Sponsor
Sheba Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Melanoma
Start date
2006-01-01
Primary completion
2012-12-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.